Diabetes Clinical Trials in San Francisco

Showing 421-440 of 453 trials

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

NCT00259727

The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.

DiabetesHIV InfectionsInsulin Resistance

US Department of Veterans Affairs80 participantsStarted Jan 2006

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)

NCT00460018

The primary aim of this study is to evaluate whether a lifestyle intervention of diet, exercise, and breastfeeding is associated with decreased postpartum weight retention and reduced plasma glucose levels, measured at 6-weeks and 1-year postpartum, among women with gestational diabetes mellitus (GDM). Secondary outcomes are postpartum levels of plasma insulin, markers of insulin resistance, adiponectin, dietary fat, physical activity, and breastfeeding duration.

Gestational Diabetes Mellitus

Kaiser Permanente180 participantsStarted Sep 2005

Oakland, California, United States • Oakland, California, United States • San Francisco, California, United States +2 more locations

TERMINATEDPhase 310 miles

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

NCT00138671

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Chronic Obstructive Pulmonary Disease.

Diabetes MellitusChronic Obstructive Pulmonary Disease

Pfizer105 participantsStarted Jan 2003

Glendale, Arizona, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +85 more locations

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Diabetes Trials in Other Cities

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

Obese Patients With Type 2 Diabetes

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Diabetes Control and Complications Trial (DCCT)

DPBRN Blood Sugar Testing in Dental Patients

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

GALLANT 6 Tesaglitazar vs. Pioglitazone

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Other Conditions in San Francisco